MEDLIOR Trademark

Trademark Overview

On Wednesday, February 19, 2020, a trademark application was filed for MEDLIOR with the United States Patent and Trademark Office. The USPTO has given the MEDLIOR trademark a serial number of 88803078. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Thursday, September 12, 2024. This trademark is owned by Medlior Health Outcomes Research Ltd.. The MEDLIOR trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing an online listing of de-identified patient datasets for purposes of health research; providing de-identified patient datasets to consumers for purposes of health research; Medical research services; pharmaceutical research services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research on the subject of pharmaceuticals; technical writing; statistical analysis and reporting services for health research; statistical evaluation of data from de-identified patient information; consulting services, namely, developing research proposals and analytical plans for consumers in the health, insurance and medical industries
medlior

General Information

Serial Number88803078
Word MarkMEDLIOR
Filing DateWednesday, February 19, 2020
Status653 - SUSPENSION LETTER - MAILED
Status DateThursday, September 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesProviding an online listing of de-identified patient datasets for purposes of health research; providing de-identified patient datasets to consumers for purposes of health research; Medical research services; pharmaceutical research services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research on the subject of pharmaceuticals; technical writing; statistical analysis and reporting services for health research; statistical evaluation of data from de-identified patient information; consulting services, namely, developing research proposals and analytical plans for consumers in the health, insurance and medical industries

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 24, 2020
Primary Code042
First Use Anywhere DateThursday, November 30, 2017
First Use In Commerce DateThursday, November 30, 2017

Trademark Owner History

Party NameMedlior Health Outcomes Research Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCalgary, AB T2C5P9
CA

Trademark Events

Event DateEvent Description
Wednesday, May 13, 2020NON-FINAL ACTION E-MAILED
Saturday, February 22, 2020NEW APPLICATION ENTERED
Monday, February 24, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 7, 2020ASSIGNED TO EXAMINER
Wednesday, May 13, 2020NON-FINAL ACTION WRITTEN
Wednesday, May 13, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 23, 2020TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, September 23, 2020DIVISIONAL REQUEST RECEIVED
Wednesday, November 4, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 4, 2020ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Thursday, November 12, 2020TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, November 12, 2020RESPONSE TO ITU OFFICE ACTION ENTERED
Thursday, November 12, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 12, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 23, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 23, 2020DIVISIONAL PROCESSING COMPLETE
Wednesday, January 13, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 13, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 13, 2021REPORT UNRESPONSIVE AMENDMENT - COMPLETED
Wednesday, January 13, 2021NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
Wednesday, January 13, 2021NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
Thursday, January 14, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 11, 2021SUSPENSION LETTER WRITTEN
Thursday, February 11, 2021LETTER OF SUSPENSION E-MAILED
Thursday, February 11, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, August 16, 2021SUSPENSION INQUIRY WRITTEN
Monday, August 16, 2021INQUIRY TO SUSPENSION E-MAILED
Monday, August 16, 2021NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, February 11, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, February 16, 2022ASSIGNED TO LIE
Wednesday, February 16, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 16, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 7, 2022SUSPENSION LETTER WRITTEN
Monday, March 7, 2022LETTER OF SUSPENSION E-MAILED
Monday, March 7, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, September 7, 2022SUSPENSION INQUIRY WRITTEN
Wednesday, September 7, 2022INQUIRY TO SUSPENSION E-MAILED
Wednesday, September 7, 2022NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, September 7, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, March 3, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, March 10, 2023ASSIGNED TO LIE
Monday, March 13, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 13, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 13, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 13, 2023SUSPENSION LETTER WRITTEN
Monday, March 13, 2023LETTER OF SUSPENSION E-MAILED
Monday, March 13, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sunday, September 17, 2023SUSPENSION INQUIRY WRITTEN
Sunday, September 17, 2023INQUIRY TO SUSPENSION E-MAILED
Sunday, September 17, 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, December 1, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Saturday, December 2, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, December 2, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 15, 2023SUSPENSION LETTER WRITTEN
Friday, December 15, 2023LETTER OF SUSPENSION E-MAILED
Friday, December 15, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, June 18, 2024NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, June 18, 2024SUSPENSION INQUIRY WRITTEN
Tuesday, June 18, 2024INQUIRY TO SUSPENSION E-MAILED
Friday, September 6, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 6, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 12, 2024SUSPENSION LETTER WRITTEN
Thursday, September 12, 2024LETTER OF SUSPENSION E-MAILED
Thursday, September 12, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, September 5, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

Related Keywords

medlior research health services providing identified medical patient purposes datasets pharmaceuticals